Will steroidal aromatase inhibitors induce rheumatoid arthritis?
作者信息
Morel Benoit, Marotte Hubert, Miossec Pierre
出版信息
Ann Rheum Dis. 2007 Apr;66(4):557-8. doi: 10.1136/ard.2006.066159.
Abstract
摘要
相似文献
1
Will steroidal aromatase inhibitors induce rheumatoid arthritis?甾体类芳香化酶抑制剂会诱发类风湿性关节炎吗？
Ann Rheum Dis. 2007 Apr;66(4):557-8. doi: 10.1136/ard.2006.066159.
2
Rheumatoid arthritis: a complication of aromatase inhibitor therapy?类风湿关节炎：芳香化酶抑制剂治疗的并发症？
Int J Immunopathol Pharmacol. 2011 Oct-Dec;24(4):1099-101. doi: 10.1177/039463201102400430.
3
Rheumatoid arthritis and aromatase inhibitors.类风湿关节炎与芳香化酶抑制剂。
Joint Bone Spine. 2011 Jan;78(1):62-4. doi: 10.1016/j.jbspin.2010.05.016.
4
Getting a grip on aromatase inhibitor-associated arthralgias.掌握芳香化酶抑制剂相关关节痛
J Clin Oncol. 2008 Jul 1;26(19):3120-1. doi: 10.1200/JCO.2008.16.7684. Epub 2008 May 12.
5
Aromatase inhibitors and musculoskeletal adverse events.芳香化酶抑制剂与肌肉骨骼不良事件。
Lancet Oncol. 2012 Apr;13(4):333-4. doi: 10.1016/S1470-2045(11)70345-X. Epub 2012 Jan 20.
6
Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.他莫昔芬和第三代芳香化酶抑制剂对乳腺癌患者更年期症状的急性影响。
Anticancer Drugs. 2004 Sep;15(8):753-60. doi: 10.1097/00001813-200409000-00003.
7
Bone safety of aromatase inhibitors versus tamoxifen.芳香化酶抑制剂与他莫昔芬的骨骼安全性比较。
Int J Gynecol Cancer. 2006;16 Suppl 2:518-20. doi: 10.1111/j.1525-1438.2006.00685.x.
8
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.绝经后乳腺癌患者辅助内分泌治疗的毒性：系统评价和荟萃分析。
J Natl Cancer Inst. 2011 Sep 7;103(17):1299-309. doi: 10.1093/jnci/djr242. Epub 2011 Jul 9.
9
Accelerated cutaneous nodulosis associated with aromatase inhibitor therapy in a patient with rheumatoid arthritis.一名类风湿关节炎患者接受芳香化酶抑制剂治疗后出现的加速性皮肤结节病。
J Rheumatol. 2009 May;36(5):1087-8. doi: 10.3899/jrheum.080648.
10
Tamoxifen or aromatase inhibitors in breast cancer: efficacy and safety.他莫昔芬或芳香化酶抑制剂治疗乳腺癌：疗效与安全性
Acta Chir Belg. 2007 Jun;107(3):240-56. doi: 10.1080/00015458.2007.11680051.
引用本文的文献
1
Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting.CDK4/6 抑制剂对辅助治疗中芳香化酶抑制剂相关肌肉骨骼综合征（AIMSS）的影响。
Breast J. 2023 May 31;2023:3614296. doi: 10.1155/2023/3614296. eCollection 2023.
2
CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience.CDK4/6 抑制剂与关节痛：单中心经验。
Med Sci (Basel). 2021 Jun 5;9(2):42. doi: 10.3390/medsci9020042.
3
Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review.芳香化酶与细胞周期蛋白依赖性激酶4/6抑制剂诱发的肌肉骨骼症状：一项系统综述
Cancers (Basel). 2021 Jan 26;13(3):465. doi: 10.3390/cancers13030465.
4
Aromatase Inhibitors-Induced Musculoskeletal Disorders: Current Knowledge on Clinical and Molecular Aspects.芳香酶抑制剂诱导的肌肉骨骼疾病：临床和分子方面的最新知识。
Int J Mol Sci. 2020 Aug 6;21(16):5625. doi: 10.3390/ijms21165625.
5
Primary antiphospholipid syndrome during aromatase inhibitors therapy: A case report and review of the literature.芳香化酶抑制剂治疗期间的原发性抗磷脂综合征：一例报告及文献复习
Medicine (Baltimore). 2019 Mar;98(13):e15052. doi: 10.1097/MD.0000000000015052.
6
Does Aromatase Inhibitors Cause Sjogren's Syndrome and Polyneuropathy?芳香化酶抑制剂会导致干燥综合征和多发性神经病吗？
World J Oncol. 2014 Aug;5(4):181-182. doi: 10.14740/wjon695w. Epub 2014 Aug 25.
7
Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology.芳香化酶抑制剂治疗对乳腺癌女性类风湿关节炎发生的影响：来自意大利风湿病学会一项基于大人群研究的结果
RMD Open. 2017 Sep 28;3(2):e000523. doi: 10.1136/rmdopen-2017-000523. eCollection 2017.
8
Aromatase inhibitors induced autoimmune disorders in patients with breast cancer: A review.芳香化酶抑制剂诱发乳腺癌患者自身免疫性疾病：一项综述。
J Adv Res. 2016 Sep;7(5):719-726. doi: 10.1016/j.jare.2016.04.001. Epub 2016 Apr 23.
9
A case of anastrazole-related drug-induced autoimmune hepatitis.一例阿那曲唑相关药物性自身免疫性肝炎病例。
Clin J Gastroenterol. 2014 Oct;7(5):414-7. doi: 10.1007/s12328-014-0512-4. Epub 2014 Jul 22.
10
Using gene expression signatures to identify novel treatment strategies in gulf war illness.利用基因表达特征识别海湾战争综合症的新型治疗策略。
BMC Med Genomics. 2015 Jul 9;8:36. doi: 10.1186/s12920-015-0111-3.
本文引用的文献
1
Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation.芳香化酶抑制剂与雌激素缺乏引起的关节痛综合征
Arthritis Rheum. 2005 Sep;52(9):2594-8. doi: 10.1002/art.21364.
2
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.他莫昔芬治疗两至三年后依西美坦用于绝经后原发性乳腺癌女性的一项随机试验。
N Engl J Med. 2004 Mar 11;350(11):1081-92. doi: 10.1056/NEJMoa040331.
3
4
The onset of rheumatoid arthritis in relation to pregnancy and childbirth.类风湿关节炎与妊娠和分娩的关系。
Clin Exp Rheumatol. 1993 Mar-Apr;11(2):171-4.
Zotero 插件